SpringWorks Therapeutics Reports Fourth Quarter and Full-Yea

SpringWorks Therapeutics Reports Fourth Quarter and Full-Year 2022 Financial Results and Recent Business Highlights

SpringWorks Therapeutics Reports Fourth Quarter and Full-Year 2022 Financial Results and Recent Business Highlights
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States , Katholieke Universiteit Leuven , Kim Diamondvice , Saqib Islam , Samantha Hilson Sandlersenior , Linkedin , Children Oncology Group , Drug Administration , Nasdaq , Trademark Office , Flanders Institute For Biotechnology , Development Rd Expenses , Springworks Therapeutics Inc , European Medicines Agency , Wall Street , Desmoid Tumors Accepted , Granted Priority Review , Date Set , Topline Data , Reneu Trial Evaluating Mirdametinib , Pediatric Patients , Associated Plexiform Neurofibromas Expected , Second Half , Dosed First Patient , Combination Study , Expanded Intellectual Property Portfolio , Strengthening Protection , Cash Equivalents , Marketable Securities , Works Therapeutics , New Drug Application , Chief Executive Officer , Business Highlights , Springwork New Drug Application , Priority Review , Prescription Drug User Fee Act , Marketing Authorization Application , Oncology Group , Maturation Antigen , Beigene Sponsored Phase , Investigational New Drug Application , United States Patent , Orange Book Listable , Full Year , Flanders Institute , Loss Attributable , Common Stockholders , Private Securities Litigation Reform Act , Springwork Annual Report , Consolidated Statements , Ended December , Balance Sheet Data , Working Capital , Kim Diamondvice President , Investor Relationsphone , Hilson Sandlersenior Director , Springworks Therapeutics ,